Latest Redmile Group, LLC Stock Portfolio
$1.51Billion | No. of Holdings #35
Redmile Group, LLC Performance
2026 Q1+0.17%
YTD+0.17%
2025+39.74%
About Redmile Group, LLC and 13F Hedge Fund Stock Holdings
On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Redmile Group, LLC reported an equity portfolio of $1.5 Billions as of 31 Mar, 2026. <br><br> The top stock holdings of Redmile Group, LLC are SRRK, KRYS, STOK. The fund has invested 29.5% of it's portfolio in SCHOLAR ROCK HLDG CORP and 11.5% of portfolio in KRYSTAL BIOTECH INC. <br><br> The fund managers got completely rid off RAPT THERAPEUTICS INC (RAPT), REPLIMUNE GROUP INC (REPL) and REPARE THERAPEUTICS INC (RPTX) stocks. They significantly reduced their stock positions in PLIANT THERAPEUTICS INC (PLRX), COGENT BIOSCIENCES INC (COGT) and IDEAYA BIOSCIENCES INC (IDYA). Redmile Group, LLC opened new stock positions in BIOMARIN PHARMACEUTICAL INC (BMRN), PRIME MEDICINE INC and ARDELYX INC (ARDX). The fund showed a lot of confidence in some stocks as they added substantially to ALX ONCOLOGY HLDGS INC (ALXO), XENON PHARMACEUTICALS INC (XENE) and SCHOLAR ROCK HLDG CORP (SRRK).
Redmile Group, LLC Equity Portfolio Value
Last Reported on: 15 May, 2026
$1.51Billion
as of May 15, 2026Redmile Group, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Redmile Group, LLC made a return of 0.17% in the last quarter. In trailing 12 months, it's portfolio return was 81.04%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| biomarin pharmaceutical inc | 9,821,300 |
| prime medicine inc | 5,536,100 |
| eupraxia pharmaceuticals inc | 5,068,000 |
| ardelyx inc | 4,392,770 |
| agomab therapeutics nv | 1,639,060 |
New stocks bought by Redmile Group, LLC
Additions
| Ticker | % Inc. |
|---|---|
| alx oncology hldgs inc | 143 |
| xenon pharmaceuticals inc | 96.2 |
| scholar rock hldg corp | 73.66 |
| annexon inc | 44.76 |
| solid biosciences inc | 8.13 |
| stoke therapeutics inc | 3.22 |
Additions to existing portfolio by Redmile Group, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| pliant therapeutics inc | -52.23 |
| cogent biosciences inc | -52.15 |
| ideaya biosciences inc | -29.77 |
| ceribell inc | -11.13 |
| dbv technologies s a | -10.64 |
| livanova plc | -8.22 |
| establishment labs hldgs inc | -8.17 |
| celldex therapeutics inc new | -7.69 |
Redmile Group, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| repare therapeutics inc | -4,124,050 |
| replimune group inc | -10,689,600 |
| rapt therapeutics inc | -30,006,300 |
| kalaris therapeutics inc | -700,140 |
Redmile Group, LLC got rid off the above stocks
Sector Distribution
Redmile Group, LLC has about 91.1% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 91.1 |
| Others | 8.6 |
Market Cap. Distribution
Redmile Group, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- MID-CAP
- SMALL-CAP
- UNALLOCATED
- MICRO-CAP
| Category | % |
|---|---|
| MID-CAP | 56.5 |
| SMALL-CAP | 29.6 |
| UNALLOCATED | 8.6 |
| MICRO-CAP | 4.5 |
Stocks belong to which Index?
About 76.2% of the stocks held by Redmile Group, LLC either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
| Index | % |
|---|---|
| RUSSELL 2000 | 76.2 |
| Others | 23.8 |
Redmile Group, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Redmile Group, LLC
Redmile Group, LLC has 35 stocks in it's portfolio. About 81.9% of the portfolio is in top 10 stocks. NRIX proved to be the most loss making stock for the portfolio. SRRK was the most profitable stock for Redmile Group, LLC last quarter.
$1.51BTotal Value
39.00Positions
15 May, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Absci Corporation Redmile Group, LLC's holding in Absci Corporation over time | 1.64% | 8,253,320 | $24.76M 1.64% | 0%unchanged 0 percentunchanged | |
 ADCT Adc Therapeutics SaAdc Therapeutics SaADCT | 3.84% | 15,470,500 | $58.01M 3.84% | 1.25%decreased 1.25 percentreduced | |
 Invivyd Inc Invivyd IncADGI Redmile Group, LLC's holding in Invivyd Inc over time | 0.23% | 2,648,660 | $3.44M 0.23% | 1.21%decreased 1.21 percentreduced | |
 Alx Oncology Hldgs Inc Redmile Group, LLC's holding in Alx Oncology Hldgs Inc over time | 1.06% | 7,964,190 | $15.97M 1.06% | 143.95%increased 143.95 percentadded | |
 Annexon Inc Annexon IncANNX Redmile Group, LLC's holding in Annexon Inc over time | 5.34% | 14,549,800 | $80.61M 5.34% | 44.76%increased 44.76 percentadded | |
 Ardelyx Inc Ardelyx IncARDX Redmile Group, LLC's holding in Ardelyx Inc over time | 0.29% | 733,350 | $4.39M 0.29% | Newnew position | |
 Atara Biotherapeutics Inc Redmile Group, LLC's holding in Atara Biotherapeutics Inc over time | 0.14% | 441,701 | $2.09M 0.14% | 0%unchanged 0 percentunchanged | |
 Beam Therapeutics Inc Redmile Group, LLC's holding in Beam Therapeutics Inc over time | 1.95% | 1,237,660 | $29.49M 1.95% | 3.75%decreased 3.75 percentreduced | |
 Biomarin Pharmaceutical Inc Redmile Group, LLC's holding in Biomarin Pharmaceutical Inc over time | 0.65% | 173,859 | $9.82M 0.65% | Newnew position | |
 Celldex Therapeutics Inc New Redmile Group, LLC's holding in Celldex Therapeutics Inc New over time | 0.55% | 261,508 | $8.30M 0.55% | 7.69%decreased 7.69 percentreduced | |
 Cogent Biosciences Inc Redmile Group, LLC's holding in Cogent Biosciences Inc over time | 1.75% | 688,036 | $26.48M 1.75% | 52.15%decreased 52.15 percentreduced | |
 DBVT Dbv Technologies S ADbv Technologies S ADBVT | 0.68% | 491,340 | $10.26M 0.68% | 10.64%decreased 10.64 percentreduced | |
 Establishment Labs Hldgs Inc Redmile Group, LLC's holding in Establishment Labs Hldgs Inc over time | 0.39% | 103,464 | $5.87M 0.39% | 8.17%decreased 8.17 percentreduced | |
 Fate Therapeutics Inc Redmile Group, LLC's holding in Fate Therapeutics Inc over time | 1.02% | 12,872,900 | $15.45M 1.02% | 0%unchanged 0 percentunchanged | |
 Ideaya Biosciences Inc Redmile Group, LLC's holding in Ideaya Biosciences Inc over time | 1.15% | 521,117 | $17.36M 1.15% | 29.77%decreased 29.77 percentreduced | |
 Immunome Inc Immunome IncIMNM Redmile Group, LLC's holding in Immunome Inc over time | 8.05% | 5,558,880 | $121.57M 8.05% | 2.79%decreased 2.79 percentreduced | |
 Krystal Biotech Inc Redmile Group, LLC's holding in Krystal Biotech Inc over time | 11.52% | 673,505 | $173.98M 11.52% | 0.62%decreased 0.62 percentreduced | |
 Livanova Plc Livanova PlcLIVN Redmile Group, LLC's holding in Livanova Plc over time | 0.46% | 108,354 | $6.89M 0.46% | 8.22%decreased 8.22 percentreduced | |
 Nurix Therapeutics Inc Redmile Group, LLC's holding in Nurix Therapeutics Inc over time | 7.94% | 7,732,810 | $119.86M 7.94% | 4.46%decreased 4.46 percentreduced | |
 Nuvation Bio Inc Nuvation Bio IncNUVB Redmile Group, LLC's holding in Nuvation Bio Inc over time | 0.9% | 3,153,260 | $13.53M 0.9% | 0.32%decreased 0.32 percentreduced | |